In this study, we found that inhibition of PLOD1 expression in osteosarcoma cells dramatically reduced the expression of p-AKT and β-catenin, while no changes of total AKT expression were observed (Figure 6(b)). This evidence concerns the gene AKT1 and osteosarcoma.